Viewing Study NCT01998958

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:17 AM
Ignite Modification Date: 2026-02-24 @ 12:13 AM
Study NCT ID: NCT01998958
Status: COMPLETED
Last Update Posted: 2025-04-29
First Post: 2013-11-25
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression
Sponsor: Janssen Research & Development, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Treatment Resistant Depressive Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Treatment resistant depressive disorder View
None Intranasal esketamine View
None Efficacy View
None SYNAPSE View
None JNJ-54135419 View